Effect of high-dose thiamine and pyridoxine on advanced glycation end products and other oxidative stress markers in hemodialysis patients: A randomized placebo-controlled study

Journal of Renal Nutrition

Volumn 16, Issue 2, 2006, Pages 119-124

  Nascimento, Marcelo M ^a,b,c   Suliman, Mohamed E ^b   Murayama, Yukio ^b   Nihi, Melissa ^a   Hayashi, Shirley Y ^b   Stenvinkel, Peter ^b   Riella, Miguel C ^a   Lindholm, Bengt ^b  

^a Faculdade Evangélica Do Paraná Brazil   (Brazil)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c Evangelic School of Medicine   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; PLACEBO; PYRIDOXINE; THIAMINE;

ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; NUTRITIONAL STATUS; OXIDATIVE STRESS; PLACEBOS; PYRIDOXINE; RENAL DIALYSIS; THIAMINE; TREATMENT OUTCOME;

EID: 33645294921     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2006.01.002     Document Type: Article

References (31)

1. D. Sell, V. Monnier Structure elucidation of a senescence cross link from human extracellular matrix. Implication of pentoses in the aging process J Biol Chem 264 1989 597 602
2. K. Wells-Knecht, E. Brinkmann, M. Wells-Knecht New biomarkers of Maillard reaction damage to patients Nephrol Dial Transplant 11 1996 41 47
3. D. Raj, D. Choudhury, T. Welbourne Advanced glycation end products A Nephrologist's perspective Am J Kidney Dis 35 2000 365 380
4. M. Kalousova, T. Zima, V. Tesar Advanced glycation end products in clinical nephrology Kidney Blood Press Res 27 2004 18 28
5. P.J. Thornalley Glycation in diabetic neuropathy Characteristics, consequences, causes, and therapeutic options Int Rev Neurobiol 50 2002 37 57
6. A.A. Booth, R.G. Khalifah, P. Todd In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways J Biol Chem 272 1997 5430 5437
7. M. La Selva, E. Beltramo, F. Pagnozzi Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions Diabetologia 39 1996 1263 1268
8. H. Stracke, H. Hammes, D. Werkmann Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats Exp Clin Endocrinol Diabetes 109 2001 330 336
9. F. Pomero, A. Molinar Min, M. La Selva Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose Acta Diabetologica 38 2001 135 138
10. V. Witko-Sarsat, M. Friedlander, C. Capeillere-Blandin Advanced oxidation protein products as a novel marker of oxidative stress in uremia Kidney Int 49 1996 1304 1313
11. M.E. Suliman, O. Heimburger, P. Barany Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy J Am Soc Nephrol 14 2003 1614 1622
12. S. Toyokuni, T. Tanaka, Y. Hattori Quantitative immunohistochemical determination of 8-hydroxy-2'-deoxyguanosine by a monoclonal antibody N45.1 Its application to ferric nitrilotriacetate-induced renal carcinogenesis model Lab Invest 76 1997 365 374
13. O. Ivanovski, D. Szumilak, T. Nguyen-Khoa The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice Kidney Int 67 2005 2288 2294
14. M. Boaz, S. Smetana, T. Weinstein Secondary prevention with antioxidants of cardiovascular disease in end-stage renal disease (SPACE) Randomised placebo-controlled trial Lancet 360 2000 23 33
15. M. Tepel, M. van der Giet, M. Statz The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure Circulation 107 2003 992 995
16. G.E. Gibson, H. Zhang Interactions of oxidative stress with thiamine homeostasis promote neurodegeneration Neurochem Int 40 2002 493 504
17. E. Descombes, A.B. Hanck, G. Fellay Water soluble vitamins in chronic hemodialysis patients and need for supplementation Kidney Int 43 1993 1319 1328
18. T. Niwa, T. Ito, E. Matsui Plasma level and transfer capacity of thiamin in patients undergoing long-term hemodialysis Am J Clin Nutr 28 1975 1105 1109
19. M.A. Allman, A.S. Truswell, D.I. Tiller Vitamin supplementation of patients receiving hemodialysis Med J Aust 150 1989 130 133
20. 6 deficiency in uremia Am J Clin Nutr 28 1975 950 957
21. J.D. Kopple, K. Mercurio, M.J. Blumenkrantz Daily requirement for pyridoxine supplementation in chronic renal failure Kidney Int 19 1981 694 704
22. T.A. Perry, A. Weerasuriya, P.R. Mouton Pyridoxine-induced toxicity in rats A stereological quantification of the sensory neuropathy Exp Neurol 190 2004 133 144
23. M.E. Suliman, J.C. Divino-Filho, P. Barany Effect of high dose folic-acid pyridoxine on plasma erythrocyte sulfur amino acids in hemodialysis patients J Am Soc Nephrol 10 1999 1287 1296
24. W.G. Schoonen, A.H. Wanamarta, V.M. van den Klein Respiratory failure and stimulation of glycolysis in Chinese hamster ovary cells exposed to normobaric hyperoxia J Biol Chem 265 1990 1118 1124
25. T.P. Degenhardt, N.L. Alderson, D.D. Arrington Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat Kidney Int 61 2002 939 950
26. E. Fragedaki, M. Nebel, N. Schupp Genomic damage and circulating AGE levels in patients undergoing daily versus standard haemodialysis Nephrol Dial Transplant 20 2005 1936 1943
27. J. Himmelfarb, P. Stenvinkel, A. Ikizler The elephant in uremia oxidant stress as a unifying concept of cardiovascular disease in uremia Kidney Int 62 2002 1524 1538
28. M. Danielski, A. Ikisler, E. McMonagle Linkage of hypoalbuminemia, inflammation and oxidative stress in patients receiving maintenance hemodialysis therapy Am J Kidney Dis 42 2003 286 294
29. P. Stenvinkel, I. Holmberg, O. Heimburger A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients Nephrol Dial Transplant 13 1998 2594 2600
30. R. Babaei-Jadidi, N. Karachalias, N. Ahmed Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine Diabetes 52 2003 2110 2120
31. G. Ramirez, M. Chen, H.W. Boyce Jr The plasma and red cell vitamin B levels of chronic hemodialysis patients A longitudinal study Nephron 42 1986 41 46